These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9687290)

  • 1. Ovine allantoic fluid contains high concentrations of activin A: partial dissociation of immunoactivity and bioactivity.
    Foulds LM; de Kretser DM; Farnworth P; Buttress D; Jenkin G; Groome NP; McFarlane JR
    Biol Reprod; 1998 Aug; 59(2):233-40. PubMed ID: 9687290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isolation of activin from ovine amniotic fluid.
    de Kretser DM; Foulds LM; Hancock M; McFarlane J; Goss N; Jenkin G
    Endocrinology; 1994 Mar; 134(3):1231-7. PubMed ID: 8119164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibin and follistatin concentrations in fetal tissues and fluids during gestation in sheep: evidence for activin in amniotic fluid.
    Wongprasartsuk S; Jenkin G; McFarlane JR; Goodman M; de Kretser DM
    J Endocrinol; 1994 May; 141(2):219-29. PubMed ID: 8046292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma.
    Robertson DM; Cahir N; Findlay JK; Burger HG; Groome N
    J Clin Endocrinol Metab; 1997 Mar; 82(3):889-96. PubMed ID: 9062502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine milk protein, a novel activin-binding protein, is present in ovine allantoic fluid.
    McFarlane JR; Foulds LM; O'Connor AE; Phillips DJ; Jenkin G; Hearn MT; de Kretser DM
    Endocrinology; 1999 Oct; 140(10):4745-52. PubMed ID: 10499534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTH-like bioactivity and immunoactivity in fetal lamb pituitaries at 0.65 and 0.95 gestation.
    Fora MA; Valego NK; Lively MO; Castro MI; Rose JC
    Reprod Fertil Dev; 1996; 8(1):195-201. PubMed ID: 8713741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin/activin beta-subunit monomer: isolation and characterization.
    Robertson DM; Foulds LM; Prisk M; Hedger MP
    Endocrinology; 1992 Mar; 130(3):1680-7. PubMed ID: 1537316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay for activin A/EDF. Method and measurement of immunoreactive activin A/EDF levels in various biological materials.
    Shintani Y; Takada Y; Yamasaki R; Saito S
    J Immunol Methods; 1991 Mar; 137(2):267-74. PubMed ID: 2013701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental changes of amino acids in ovine fetal fluids.
    Kwon H; Spencer TE; Bazer FW; Wu G
    Biol Reprod; 2003 May; 68(5):1813-20. PubMed ID: 12606398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation and application of a two-site enzyme-linked immunosorbent assay for activin-AB.
    Evans LW; Muttukrishna S; Knight PG; Groome NP
    J Endocrinol; 1997 May; 153(2):221-30. PubMed ID: 9166111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follistatin and activin A in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy.
    Riley SC; Balfour C; Wathen NC; Chard T; Evans LW; Groome NP; Wallace EM
    Hum Reprod; 1998 Sep; 13(9):2624-8. PubMed ID: 9806296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased midtrimester amniotic fluid activin A: a risk factor for subsequent fetal death.
    Petraglia F; Gomez R; Luisi S; Florio P; Tolosa JE; Stomati M; Romero R
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):194-7. PubMed ID: 9914603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids.
    Krummen LA; Woodruff TK; DeGuzman G; Cox ET; Baly DL; Mann E; Garg S; Wong WL; Cossum P; Mather JP
    Endocrinology; 1993 Jan; 132(1):431-43. PubMed ID: 7678220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heparin binding site of follistatin is involved in its interaction with activin.
    Sumitomo S; Inouye S; Liu XJ; Ling N; Shimasaki S
    Biochem Biophys Res Commun; 1995 Mar; 208(1):1-9. PubMed ID: 7887917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive and specific in vitro bioassay for activin using a mouse plasmacytoma cell line, MPC-11.
    Phillips DJ; Brauman JN; Mason AJ; de Kretser DM; Hedger MP
    J Endocrinol; 1999 Jul; 162(1):111-6. PubMed ID: 10396027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial characterization of inhibin, activin, and follistatin in the term human placenta.
    de Kretser DM; Foulds LM; Hancock M; Robertson DM
    J Clin Endocrinol Metab; 1994 Aug; 79(2):502-7. PubMed ID: 8045969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feto-placental hypoxemia regulates the release of fetal activin A and prostaglandin E(2).
    Jenkin G; Ward J; Hooper S; O'Connor A; de Kretser D; Wallace E
    Endocrinology; 2001 Feb; 142(2):963-6. PubMed ID: 11159871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of high affinity binding sites for inhibin on ovine pituitary cells in culture.
    Hertan R; Farnworth PG; Fitzsimmons KL; Robertson DM
    Endocrinology; 1999 Jan; 140(1):6-12. PubMed ID: 9886800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibin and activin in embryonic and fetal development in ruminants.
    Jenkin G; McFarlane J; de Kretser DM
    J Reprod Fertil Suppl; 1995; 49():177-86. PubMed ID: 7623312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1).
    Wang QF; Khoury RH; Smith PC; McConnell DS; Padmanahban V; Midgley AR; Schneyer AL; Crowley WF; Sluss PM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1434-41. PubMed ID: 8636347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.